AI-enhanced OCT Imaging for Pre-surgical Margin Detection of Basal Cell Carcinoma

Starting soon

Conditions studied: Basal Cell Carcinoma of Skin

In brief

Basal cell carcinomas (BCCs) are the most common human malignancy, affecting about 2 million Americans each year. Mohs micrographic surgery (MMS) removes tissue by sequential excision. Costs for MMS could be reduced if the number of necessary excision stages were decreased by a more accurate initial tumor margin assessment. The goal of this observational study is to learn if Optical Coherence Tomography (OCT) used in conjunction with artificial intelligence algorithms is accurate in the detection of superficial BCC margins prior to MMS. This study also aims to determine if AI-OCT guided margin delineation can reduce the number of stages in MMS. Researchers will first focus on validating AI-OCT as a method for accurately detecting BCCs. A follow-up study would then address the guided pre-surgical margin delineation.

Key facts

Study ID

NCT07358637

Run by

Henry Ford Health System

People needed

30

Starts

2026-09-01

Expected to finish

2028-12-01

Last updated by the study team

2026-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or Female, ages 18 or older
• at least one biopsy proven superficial or nodular BCC
• willingness to have photographs taken of the treatment area
• ability to understand and willingness to sign a written informed consent document

You may not qualify if…

• infiltrative, micronodular, or morpheaform BCC
• pregnant women
• subjects not willing to have a biopsy taken from the treatment area
• subjects with herpes simplex virus infection in the treatment area

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.